Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VTL | Vital Therapies, Inc. | 1.50% | 13.51 | 3.3% | $792.68m | |
| AMGN | Amgen Inc. | 0.97% | 206.00 | 1.3% | $773.44m | |
| GILD | Gilead Sciences, Inc. | 1.54% | 64.11 | 0.9% | $388.34m | |
| CELG | Celgene Corporation | 0.51% | 95.22 | 1.3% | $348.72m | |
| BIIB | Biogen Inc. | 1.74% | 235.72 | 1.3% | $309.32m | |
| ILMN | Illumina, Inc. | 0.87% | 288.65 | 3.5% | $303.84m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.16% | 187.09 | 1.9% | $267.03m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.65% | 112.68 | 2.0% | $250.97m | |
| EXAS | Exact Sciences Corporation | -1.39% | 118.16 | 24.1% | $248.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.52% | 298.38 | 2.6% | $217.05m | |
| A | Agilent Technologies, Inc. | 0.96% | 71.76 | 1.6% | $206.55m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.71% | 120.31 | 14.7% | $153.85m | |
| INCY | Incyte Corporation | 1.68% | 84.52 | 2.5% | $100.26m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.19% | 77.41 | 4.3% | $94.71m | |
| GHDX | Genomic Health, Inc. | -0.56% | 74.22 | 1.8% | $90.42m |
Company Profile
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate, for use in those life threatening conditions in which cellular oxygen deprivation is the basis for significant unmet medical needs. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.